Delivery Order SPE2DB22D2005-SPE2DB24FJTF1

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,080.72 firm fixed-price contract is for the delivery of 4564383439 units of Fexofenadine HCL 180 mg tablets. The award has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,760.02 firm fixed price contract provides 4,562,878,752 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $1,931.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Fexofenadine HCL 180 mg tablets, a prescription medication, with a period of performance through July 2, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,352 units of Fexofenadine HCl 180 mg tablets. The firm-fixed-price contract has a ceiling value of $1,093.98 and will run through August 6, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,533 units of Fexofenadine HCL 180 mg tablets. The $1,340.43 ceiling value contract has a completion date of September 21, 2022. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025, has an extensive history of providing pharmaceutical and medical products...
This is a $2,501.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,198,982 units of fexofenadine HCl 180 mg tablets. The contract has an ultimate completion date of February 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,147.76 firm fixed-price contract is for the delivery of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 16, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 500 packs of Fexofenadine HCl 180 mg tablets. The $1,034.60 contract has an ultimate completion date of August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite-delivery contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation for providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.44, is for the delivery of Fexofenadine HCL 180 mg Tablets. This is a firm fixed-price delivery order contract with a completion date of May 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $1,640.52 firm fixed price contract is for the delivery of 4,558,478,347 units of Fexofenadine HCL 180 mg tablets. This order is made under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and will...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJTF1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fexofenadine HCL 180 mg tablets. The $1,813.85 firm-fixed-price contract has a completion date of September 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to provide a wide range of pharmaceutical and medical products to support military treatment programs, veterans' healthcare, and other government beneficiaries nationwide. This contract award is not associated with a set-aside program.

Generated 12/25/24, 9:03 AM